Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.
At Multiple Sclerosis News Today, stories about the keto diet, myelin repair, and vitamin D topped this year's most-read list ...
People with higher blood levels of certain manufactured compounds that persist in the environment are more likely to be ...
A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...
Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.
Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...
Triggers include warmer temperatures, low humidity, atmospheric pressure, and stress. Better understanding of these triggers can improve MS management. Relapses in people with relapsing-remitting ...
As multiple sclerosis (MS) progresses, some people transition to secondary progressive multiple sclerosis (SPMS) — a stage of MS in which symptoms gradually worsen over time, often with fewer relapses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback